Technomark News: January 2021

Wednesday, January 27, 2021

Farm Animal Healthcare Market Size, Demand, Analysis, On-Going Trends, Status, Forecast 2025

Farm animals are the domesticated animals adopted for the production of milk and meat products. Generally adopted farm animals include cattle, poultry, aqua, swine, and sheep among others. The various diseases occur to farm animals include foodborne diseases, parasitic diseases; infectious diseases are due to the lack of nutrition fortified feed. Vaccines are commonly administered to the farm animals for the prevention of diseases and improve the immunity of the animals.

Some of the players in farm animal healthcare market are:
Alltech Inc. (U.S.), Boehringer Ingelheim GmbH (Germany), Zoetis, Inc. (Pfizer) (U.S), Virbac AH Inc. (France), Elanco (Eli Lilly and Co.) (U.S.), Bayer HealthCare LLC, (Bayer AG) (Germany), Merck Animal Health (Merck & Co. Inc.) (U.S.), Dechra Pharmaceuticals (U.K.), and Ceva Sante Animale S.A. (France) to name a few.

The global farm animal healthcare market is growing at a healthy CAGR due to increase in the adoption of farm animal. Increase in the population preferring for healthy meat and dairy products, rise in the prevalence of foodborne diseases in animals, increase in the research and development in animal health medicine, and rise in the income for pet owners might fuel the farm animal healthcare market over the forecast period. In addition, increase in the demand for the animal source protein, the rise in the awareness about farm animal health, favourable government initiations to promote animal health, an increase in the expenditure on animal welfare might bolster the farm animal healthcare market in the future. However, stringent regulatory policies for the approval of veterinary medicines such as vaccines, high cost for the diagnosis and treatment of diseases, and strict regulations for the use of antibiotics in the animal might hamper the farm animal healthcare market over the forecast period.

Active Pharmaceutical Ingredient (API) Market 2019 Share, Trend, Segmentation and Forecast to 2025

Active pharmaceutical ingredient (API) Market is a part of the drug that produces a pharmacological effect. Some drugs such as combination therapy have multiple active pharmaceutical ingredients (API) to treat different symptoms in different ways. API’s provide health benefits and play a vital role in prevention, treatment and diagnosis. Active Pharmaceutical ingredients may synthesize by a chemical process, biotechnological process, and various other processes. Active pharmaceutical ingredients used for making the wide range of drugs that used to treat chronic diseases such as cancer, metabolic disorders, cardiovascular disorders, and neurological disorders, and others. Some market players manufacture their own API and others buy from other API manufacturing companies to make drug formulations.

Some of the players in API market are:
Pfizer, Inc. (U.S.), Sanofi (France), Lonza Group (Switzerland), Boehringer Ingelheim (Germany), Novartis AG (Switzerland), GlaxoSmithKline plc (U.K.), Bristol-Myers Squibb (U.S.), Zhejiang Hisun Pharmaceutical Co., Ltd. (China), Aenova Group GmbH (Germany), Catalent, Inc. (U.S.), Teva Pharmaceutical Industries Ltd., (Israel) Aurobindo Pharma Limited (India), Eli Lilly and Company (U.S.), AbbVie Inc. (U.S.)., and Merck & Co., Inc. (U.S.) to name a few.

Active pharmaceutical ingredient (API) market is driven by various factors such as the increase in the incidence of chronic diseases, and penetration of healthcare systems in underdeveloped countries increased the consumption of drugs are expected to fuel the growth of API market. Furthermore, a surge in healthcare spending, development of healthcare infrastructure around the world enables boost the growth of active pharmaceutical ingredients market. However, unfavourable drug pricing policies in some countries and stringent regulatory requirements are hampering the Active Pharmaceutical Ingredient Market

Next Generation Sequencing Market Growth by 2025 – Industry Analysis, Size, Share, Trends, Key Vendors, Drivers and Forecast

Next-generation sequencing is the process of sequencing DNA strands similar to the nucleotides in a DNA molecule. Next-generation sequencing is carried by massive parallelization. Next-generation sequencing reduces the requirements for the fragment-cloning method used in sequencing of the genomes by Sanger’s method. Due to high accuracy, precise results, and low cost, and with low sample, next-generation sequencing is preferred over the Sanger’s method. It is commonly used in oncology studies, biomarker discovery, agricultural and animal research, personalized medicine, and others. In addition, re-sequencing of targets, identification of binding sites of a transcriptional factor, and non-coding RNA expression profiling are other applications of next-generation sequencing.

Some of the players in global next-generation sequencing market are:
Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), Pacific Biosciences (Danaher Corporation) (U.S.), Thermo Fisher Scientific Inc. (U.S.), Qiagen N. V. (Germany), Beijing Genomics Institute (China), PerkinElmer, Inc (U.S.), F. Hoffmann La Roche AG (Switzerland), Genomatix GmbH (Germany), Oxford Nanopore Technologies (U.K.), and Eurofins Scientific (U.S.) to name a few.

Healthcare BPO Market Outlook to 2025: Emerging Trends and Will Generate New Growth Opportunities Status

Business Process Outsourcing (BPO) is a process where healthcare providers select the most appropriate third party vendors for some of the specific business procedures. It allows the hospitals and medical professionals to spend their energy and valuable time on patient care rather than doing some paper work in the office. Healthcare BPO is a solution for clients to adopt intelligent approaches that will support the organization to reduce the cost pressures and increase in the overall productivity. Healthcare BPO market provides various solutions, such as front-end services, customer account setup, billing & account receivables, provider network services, enrollment services, claims services, Medicare services, membership services, and pharmacy benefits management.

Some of the top players operating in the healthcare BPO market are:
IQVIA,HCL Technologies Limited, Accenture, Eli Global, IBM Corporation, Genpact Limited, Parexel, Sutherland, Hewlett-Packard Inc., Truven Health Analytics, United Health Group, Cognizant, Lonza Group Ltd, Accretive Health, Inc., Tata Consultancy Services Ltd, Xerox Corporation, Infosys Limited., and many others.

Shingles Vaccine Market 2019-2025: Trends, Technology, Opportunities and forecasts by 2025

Shingles is known as Herpes Zoster which causes a blistering painful rash on the skin which lasts from 2 to 4 weeks. But, for some people, the pain may last for months or years. This pain is called as (PHN) Post Herpetic Neuralgia, which is a common complication of shingles and it’s occurrence increases with age.

Some of the players in global shingles vaccine market:
Merck& Co., Inc. (U.S.), GlaxoSmithKline plc (UK), Cipla Inc. (India), Pfizer Inc. (U.S.)

Increase in the prevalence and incidence of shingles disease around the world and increase in the global ageing population is expected to enhance the growth of shingles vaccine market across the globe. But, lack of awareness, high cost of the vaccination, unfavourable insurance coverage is major restraints of the global shingles vaccine market.

Influenza Vaccine Market 2019-2025: Industry Analysis, Geographical Segmentation, Drivers, Challenges, Trends and Forecasts

Influenza is commonly known as “flu” or “seasonal flu” caused by influenza virus. The symptoms of influenza can be mild to severe ranging from fever to pneumonia. Influenza mainly affected by three type’s influenza virus, called type A, type B and type C. Influenza virus generally spread through the air by coughing and sneezing or touching contaminated surfaces by a virus. Influenza can be diagnosed by testing throat, sputum and nose. Numbers of rapid tests are available for detecting influenza virus. Influenza can be treated with antiviral drugs or prevented by administering influenza vaccine and several other fluid management methods. Influenza virus spreads around the world in yearly outbreaks that result in millions of severe illness and thousands of deaths across the world. WHO every year predicts few strains which are expected to circulate in following year, that allows pharmaceutical companies to develop influenza vaccine against these stains.

Some of the players in the influenza vaccines market include:
GlaxoSmithKline plc., Seqirus (CSL Limited), AstraZeneca, Sanofi Pasteur Inc., Sinovac Biotech Ltd., Novavax, Inc., DAIICHI SANKYO COMPANY, LIMITED., Mitsubishi Tanabe Pharma., Protein Sciences Corporation to name a few.

Multi Drug Resistant Antibiotics Market Boosting the Growth Worldwide: Market Dynamics and Trends, Efficiencies Forecast 2025

Since the discovery of the penicillin in 1928, large amount of antibiotics are used for human therapy, as well as for farm animals and even for fish in aquaculture, resulted in the selection of pathogenic bacteria resistant to multiple drugs. This multidrug-resistant may be generated by two mechanisms. One is bacteria may accumulate multiple genes, each coding for resistant to the single drug, within a single cell. Another mechanism is increased gene expressions that code for multidrug efflux pumps, effects a wide range of drugs. Multi drug resistant bacteria are formed due to the excessive use of antibiotics in various applications such as prophylactic use for surgery, or immunocompromised patients and other applications. Multi drug resistant antibiotics are the new generation antibiotics that fight against the drug resistant bacteria.

Some of the players in Multi-Drug Resistant Antibiotics Market are:
F. Hoffmann-La Roche AG (Switzerland), Achaogen Inc. (U.S.), Acetlion Pharmaceuticals (Switzerland), Sanofi S.A (France), Johnson & Johnson Servieces Inc. (U.S.), Pfizer Inc. (U.S.), Otsuka Pharmaceutical (Japan), and Eli Lilly and Company (U.S.) to name a few.

Hepatitis Treatment Market Outlook to 2025: Emerging Trends and Will Generate New Growth Opportunities Status

Hepatitis is the disease characterized by the inflammation of the liver. Hepatitis mainly occur due to the viral infections, heavy alcohol intake, consumption of hepatotoxic drugs, blood transfusions and autoimmune diseases among others. Hepatitis is classified as hepatitis A, B, C, D, E in which hepatitis A, B, C mostly occurs in humans. The symptoms associated with hepatitis include poor appetite, whites of eyes, discoloration of skin, vomiting, abdominal pain, and diarrhoea among others. Hepatitis can be prevented by the administration of vaccines in newborn babies.

Some of the players in the global hepatitis treatment market include:
Hoffmann- La Roche Ltd. (Switzerland), Gilead Sciences (U.S.), Novartis AG (Switzerland), Bristol-Myers Squibb (U.S), GlaxoSmithKline, plc., Merck and Co, Inc. (U.S), Johnson & Johnson Services, Inc. (U.S.), AbbVie Inc. (U.S.), Novira Therapeutics Inc. (U.S.), Eiger Biopharmaceuticals (U.S.)

Respiratory Syncytial Virus (RSV) Vaccines Market Key Players, Supply Chain and Analysis, Application, Market Drivers, Restraints, in-Depth Analysis, Forecast to 2030

Human Respiratory Syncytial Virus (RSV) is a leading cause of respiratory diseases, it often spreads from respiratory secretions through close contact with an infected person. The virus causes infections at all ages, but young infants of 1-3 months of age have highest incidence rate. In severe cases RSV can lead to bronchiolitis and pneumonia in babies. According to WHO, RSV has been estimated to cause 34 million acute lower respiratory tract infections (LRTI) in young children annually. RSV is a high-priority target for vaccine development because there are no approved products to protect against the respiratory virus. Moreover, it has also estimated that in United States, by the age of two, nearly all children are likely to be infected with RSV.

Increasing incidences of respiratory infection, rising neonatal population, development of drugs & vaccines with better effectiveness and limited drug toxicity can be attributed to the growing demand for global respiratory syncytial virus vaccines market in the coming years. For instance, NOVAVAX, Inc. is projected to launch the RSV F vaccine to prevent RSV infection by 2020.

Major Key Players of the Respiratory Syncytial Virus (RSV) Vaccines Market are:
GlaxoSmithKline, Novavax, Johnson & Johnson’s Janssen, AstraZeneca’s MedImmune and Bavarian Nordic

E-Health Market: Segmented by Application and Geography Trends, Growth and Forecasts to 2030 – IBM, Motion Computing, Epocrates

E-health or offline health as it is so-called is the mode of delivery of solutions regarding the use of telecommunications and technologies such as the computer, the internet and mobile devices. E-health outgrew the need for keeping documentation and tracking of patient’s health and procedures particularly and for most insurance companies.

E health care encompasses several ranges of systems and products it has to offer that are the edge of medicine and healthcare technology. Following are some products Electronic health records, E-prescribing, computerized physician entry, clinical decision support system, telemedicine, consumers health information databases, M-health, healthcare information systems and much more.

Major Key Players of the E-Health Market are:
IBM, Motion Computing, Epocrates, etc

Monday, January 25, 2021

Varicella Vaccine Market 2019 Industry Key Players, Trends, Sales, Supply, Demand, Analysis & Forecast to 2030

The Global Varicella Vaccine Market is estimated to account for over US$ 3,256.1 million by 2019. The market is anticipated to grow at a CAGR of 12.3% from 2020 to 2030.

The growth of the global varicella vaccine market can be attributed to several factors, which has led to its wide-scale adoption. Better access to vaccines worldwide and growth of pediatric & adult population are anticipated to further contribute to the substantial growth of market between 2019 and 2030. However, complex government rules & regulations monitoring R&D and clinical studies of vaccine are likely to restrain the market to a certain extent.

Top Players:

Some of the prominent players in the varicella vaccine market include Merck & Co., Inc., GlaxoSmithKline plc., Shanghai Biological Products Research Institute Co., Ltd., BIKEN, Green Cross, Changchun BCHT Biotechnology Co., Novo and SK bioscience among others.

Photodynamic Therapy Market to See Huge Growth at a CAGR of 16.6% by 2030 | Impacts Analysis of COVID-19

Photodynamic Therapy Market accounted for over US$ 900 million in 2019. The market is anticipated to grow at a CAGR of 16.6% from 2019 to 2030.

The market growth can be attributed to several factors, which have led to its wide-scale adoption. The increasing prevalence of skin disorders & cancers and the approval of new biologics for photodynamic therapy are anticipated to further contribute to this substantial market growth during the forecast period. However, risks and side effects associated with the therapy are likely to restrain market growth to a certain extent.

Top Players:

Some of the prominent players in the photodynamic therapy market include Sun Pharmaceutical Industries Ltd., BIOFRONTERA AG, Theralase Technologies Inc., LUMIBIRD, Quest PharmaTech Inc., Modulight, Inc., Galderma, Suslaser.com, Biolitec AG, and Bausch & Lomb, among others.

Pen Needles Market Shows Rapid Growth at CAGR of 10.5% by 2030 | Impacts of COVID-19

Pen needles market accounted for over US$ 1,126.1 million in 2019. It is anticipated to grow at a CAGR of 10.5% from 2020 to 2030.

Industry Overview

The new study made on Pen Needles market includes crucial information on market share, market size, and growth rate for the forecast period 2020 – 2030. The study highlights deep analysis on the major drivers of the market, restraints, and challenges to help the business owners, suppliers, and marketing personnel in planning effective strategies for the forecast period. This will help the business and manufacturers to lead the market and gain prominent position in future. The report also presents vital information through graphical representation on factors like table, charts, and statistics.

COVID-19 Impact:

The industrial report mentions about the influence of the ongoing COVID-19 pandemic. The outbreak has caused disturbances in several industries and has hammered the logistics, resulting in delayed deliveries and cancellation of product demand. The Pen Needles report proficiently explains about the resulting factors and concerns of manufacturers. Researchers have also well-explained about how the producers and providers will tackle with the ongoing epidemic and the key strategies to be adopted post pandemic for turning their businesses back to normal.

Major Players Covered in this Report are:
UltiMed, Inc., Novo Nordisk A/S, Allison Medical, Terumo Corporation, Becton, Dickinson & Company, GlucoRx Ltd, B. Braun Melsungen AG., Ypsomed AG, HTL-STREFA S.A., and Owen Mumford Ltd, among others.

Dexamethasone Market 2020: Overview and Introduction, Growth Opportunities and Business Strategies by 2030

Dexamethasone is basically a steroid that is used to treat different conditions including immune system, hormone, arthritis, blood, hormone, allergic reaction, eye condition, and certain skin conditions as well. It is also used to treat the bowel disorders, breathing issues, and few cancers. The said steroid is applied as a test for Cushing’s syndrome (adrenal gland disorder). This type of medication is a corticosteroid hormone, which decreases the body’s natural defensive response and also decreases the symptoms like allergic-related reaction and swelling. Using dexamethasone is usually recommended to be consumed through mouth (orally) or as directed by the patient’s physician.

The market growth can be attributed to several factors, which has led to its wide-scale adoption. Growing prevalence of asthma & allergic diseases and increasing demand of dexamethasone drug worldwide for the treatment of COVID-19 are anticipated to fuel the demand of dexamethasone in the coming years. However, issues with quality control and possibility of shortage of drug are likely to restrain the market growth to a certain extent.

Dexamethasone Market Prominent Players:

Some of the prominent players operating in the dexamethasone market include Allergan, Ocular Therapeutix, Inc., Zydus Cadila, Cadila Pharmaceuticals, Fresenius Kabi USA, GLS pharma ltd, Pfizer Limited, Novartis AG, Mylan N.V. Sun Pharmaceutical Industries Ltd., among others.

Contract Research Organization Services Market is Big Booming with Business Experts Ideas by Top Companies by 2030

The Global Contract Research Organization Services (CROs) Market gives us an in-depth overview of the research trends for the Year 2019-2030. This Report studies the industry on various parameters such as Industry Growth & Revenue by Manufacturers, Company Profiles, Growth Forecasts. It also provides with important credentials such as the history, various expansions and trends, trade overview, regional markets, trade and also market competitors. According to the report, the Global Contract Research Organization Services (CROs) Market is estimated to account for over US$ 40 Billion by 2019. The market is anticipated to grow at a CAGR of ~7.0% from 2019 to 2030.

Top Players:

Some of the prominent players in the contract research organization services (CROs) market include IQVIA, Covance Inc., Parexel International Corporation., PRA Health Sciences., PPD, Inc., ICON plc, Syneos Health., Charles River, Medpace, Inc. and WuXi AppTec among others.

Drug Safety & Pharmacovigilance Software Market Trends, and Forecast 2020-2030: Present Scenario, User Demand, Growth Analysis and Regional Overview

The global drug safety and pharmacovigilance software market accounted for over US$ 148.4 Million in 2019. It is anticipated to grow at a CAGR of 6.3% from 2020 to 2030.

The growth of the drug safety and pharmacovigilance software market can be attributed to several factors such as the increasing adoption of pharmacovigilance software by outsourcing companies and the rising incidents of Adverse Drug Reactions (ARDs). Contract research organizations are actively participating in the research & development activities following the rising prevalence of chronic diseases across the globe, which is likely to boost the overall market growth. Additionally, rising patient safety issues and surging adverse effects resulting from certain drug consumption may boost the global drug safety and pharmacovigilance market. This may also have a direct correlation with the availability of clinical trial services and decreased medical spending, and hence the potential growth demand for the future. However, the lack of awareness and knowledge regarding ADRs and pharmacovigilance among healthcare professionals is restraining growth of the drug safety and pharmacovigilance software market.

Drug Safety & Pharmacovigilance Software Market Prominent Players:

Some of the key players operating in the drug safety & pharmacovigilance software market include ArisGlobal LLC, Anju software, AB-cube, Sarjen Systems Pvt. Ltd, United BioSource LLC, Umbra Global, 7Ennov, Oracle, Sparta Systems Inc, and EXTEDO, among others.

Infection Control Market Industry Trends, Market Share, Growth Opportunities and Business Strategies By 2030

Market Industry Reports (MIR) has published a new report titled “Infection Control Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020–2030.” According to the report, the global infection control market was estimated to be over US$ 19.8billion in 2019. It is anticipated to grow at a CAGR of 6.4% from 2020 to 2030.

Incessantly rising incidence of infectious diseases worldwide is a major factor propelling the growth of the infection control market. The cases of hospital-acquired infections is increasing globally and itrequires efficient control measures to be undertaken to contain the infection spread. For instance, it has been estimated that every year, about 1 in 25 U.S. hospital patients are diagnosed with at least one infection related to hospital care.Increasing government initiatives for curbing the spread of infectious diseases, growing number of surgical procedures, rising growing geriatric population and increasing incidence of chronic diseasesare some of the other factors fueling the market growth.However, increasing risk of microbial resistance and inappropriate sanitization practices are some of the key factors that might hinder the growth of the infection control market to a certain extent.

Infection Control Market Prominent Players:

Some of the prominent players operating in the global infection control market are 3M, STERIS plc.,MMM Group, Cantel Medical, Metrex Research, LLC., Reckitt Benckiser Group plc., Pal International, MELAG Mediz intechnik GmbH & Co. KG,Belimed and Getinge AB among others.

Genotyping Assay Market Outlook 2020- Insights, Growth Analysis, Future Trends, Forecasts To 2030

Market Industry Reports (MIR) has published a new report titled “Genotyping Assay Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” The global genotyping assay market was valued at over US$ 7 Bn. in 2017 and is anticipated to grow at a CAGR of 21.8% from 2019 to 2030. The growth of this market can be attributed to the factors such as, the reducing prices of DNA sequencing, technological advancements, growing awareness on customized medicine, and rising importance of the method in drug development.

Increasing number of genetic disorders to propel the market growth

The global genotyping assay market is propelled by a number of factors. One among them is the increase in the number of genetic diseases all around the world. Following that is the general awareness regarding personalized medicine all around the world especially in the developed regions of the world. According to the Parkinson’s Foundation, more than 60 thousand people are diagnosed with the major genetic disorder, Parkinson’s disease in the U.S. every year. Moreover, the number is expected to reach 1 million by 2020.

Top Players:

Key players in the global genotyping assay market are Thermo Fisher Scientific, Illumina, QIAGEN, Agilent Technologies, Danaher Corporation, Roche Diagnostics, GE Healthcare, Fluidigm Corporation, PerkinElmer, Eurofins Scientific, Bio-Rad Laboratories, Pacific Biosciences of California, GENEWIZ, and Integrated DNA Technologies.

Medical Holography Market Trends, Applications and Future Demands at a CAGR of 32.7% from 2030

Market Industry Reports (MIR) has published a new report titled “Medical Holography Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global medical holography market is estimated to be over US$ 200.0 Mn in 2017. It is anticipated to grow at a CAGR of 32.7% from 2019 to 2030.

The continual growth of the medical holography market can be attributed to several factors which have led to wide scale adoption of products and several devices, which are extensively used for better understanding of human anatomy. Moreover, the growing demand for advanced medical imaging technology across the globe coupled with increasing investment in the field of R&D is anticipated to further contribute to the substantial growth of the global medical holography market between 2019 and 2030.To further ensure product penetration and to educate about product technology, key players in medical holography have adopted strategies of placing its products in educational institutions. To support this, Western University of Health Sciences has equipped its facilities with latest medical holographic devices from zSpace. Devices like 3D projection monitors have been installed to educate students and promote its products.

Major Players in the Medical Holography Market

The prominent players in the global medical holography market are RealView Imaging Ltd., Mach7 Technologies Ltd., Holoxica Ltd., Ovizio Imaging Systems, ZSpace, Inc., Lyncée Tec SA, Zebra Imaging, EchoPixel, Inc., and Holografika Kft among others.

Microcatheters Market 2020 – Impact of COVID-19, Future Growth Analysis and Challenges to 2030

Market Industry Reports (MIR) has published a new report titled “Global Microcatheters Market – Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global microcatheters market is estimated to be US$ 222.3 Mn in 2019. It is anticipated to grow at a CAGR of 7.8% from 2019 to 2030.

The growth of the microcatheters market can be attributed to several factors such as growing target patient population of cardiovascular diseases, neurovascular disorders, and cancer, growing number of Ambulatory Care Centers & Office Based Labs (OBL) and increasing focus on R&D by Key Players. Moreover, improved hospital infrastructure in developed countries, rise in medical tourism and increase in advantages of minimally invasive procedures are expected to drive the microcatheter market during the forecast period. To obtain better insights regarding the market scenario prominent players are increasingly focusing on collaborative initiatives and various product launches. For instance, Merit Medical Systems, Inc. launched Merit Pursue Microcatheter, a small distal microcatheter designed for pushability and trackability through small and tortuous vessels.

Top Players:

The prominent players in the global microcatheters market are ASAHI INTECC CO., LTD., Boston Scientific Corporation, BTG International Ltd., DePuy Synthes (Johnson & Johnson Services, Inc.), Medtronic, Merit Medical Systems, Penumbra, Inc, Stryker, Teleflex Incorporated and Terumo Medical Corporation.

Friday, January 22, 2021

Wearable Injectors Market 2020 – Covering Impact of COVID-19, Developments, SWOT Analysis by Global Top Companies Forecast 2030

Wearable injectors market is estimated to be over US$ 4.5 Bn in 2017. It is anticipated to grow at a CAGR of 12.1% from 2019 to 2030.

Increasing adoption of wearable injectors can be attributed to rising awareness, disposable incomes, and implementation of advanced drug delivery technologies. Moreover, rising prevalence of chronic disorders is anticipated to contribute substantially to the growth of the global wearable injectors market between 2019 and 2030.Educational establishments, namely Wyss Institute, have initiated partnership with KeepSmilin4Abbie Foundation, to develop wearable devices for both swift detection of anaphylaxis and automated treatment of the same by means of epinephrine delivery.

Major Players in the Wearable Injectors Market

The prominent players in the global wearable injectors market are Medtronic, Insulet Corporation, Tandem Diabetes Care, Amgen, Ypsomed, Becton Dickinson and Company, Enable Injections, Debiotech, Inc., Cellnovo, and Valeritas among others.

Electronic Drug Delivery Systems Market Set For Rapid Growth In The Forecast Period 2020–2030

The Global Electronic Drug Delivery Systems Market accounted for over US$ 7.6 billion in 2019. It is anticipated to grow at a CAGR of 8.5% from 2020 to 2030.

The success of the therapy and improvements in the condition of patients are dependent on the formulation of dosage form and the exact delivery of the drug to the desired organ. Electronic Drug Delivery Systems (EDDS) is an important innovation in the field of drug delivery systems as it combines controlled drug release, patient monitoring, and real-time wireless communication. It comprises of medical devices, which are used to infuse drugs, growth hormones, and medicines of the desired quantity in patients. These systems enable patients to administer the therapy and make patients independent of caregivers, drug regimens, and medical professionals, thus reducing the overall healthcare expenditure.

Top Players:

Some of the prominent players in the global electronic drug delivery systems market include Merck KGaA, Medtronic, F. Hoffmann-La Roche Ltd, United Therapeutics Corporation, Insulet Corporation., Bayer AG, Novo Nordisk A/S, Amgen Inc., Companion Medical, Tandem Diabetes Care, Inc., and others.

Biobanking Market Demand in Future 2020-2030 by Focusing Covid 19 Impacts

Biobanking market is estimated to be over US$ 2.1 Billion in 2019. It is anticipated to grow at 7.5% CAGR from 2019 to 2030.

Irreproducibility of research is one of the major factor for the failure of translating basic research results into tangible solutions. For addressing the problem development of biobanks plays a vital role in providing necessary infrastructure for high quality assurance and control measures by providing safe & reliable spaces for storing material which can be used for repeated testing which in turn will lead to trustworthy scientific results. Hence the increasing awareness and concern for development of novel drugs with the support of biobanking is promoting the market growth. Moreover, the rising prevalence of cancer globally is promoting the development of new solutions to fight cancer. For instance, according to World Health Organization, cancer accounted for around 9.6 million deaths in 2018. Hence the increasing setup of cancer biobanks for systematic storage of cancer tissues and associated data is promoting the growth of the market. However, the instability in consistent funding hampers the growth of biobanking Market.

Biobanking Market Prominent Players

Some prominent players in the biobanking market include Thermo Fisher Scientific Inc., PHC Holdings Corporation, QIAGEN, Becton, Dickinson and Company, Merck KGaA, Hamilton Company, Tecan Trading AG, Cell&Co, Promega Corporation and Brooks Life Sciences among others.

Hemodynamic Monitoring Systems Market Set For Rapid Growth In The Forecast Period 2020–2030

The global hemodynamic monitoring systems market was estimated to be over US$ 910million in 2019. It is anticipated to grow at a CAGR 6.2% from 2020 to 2030.

The growth of hemodynamic monitoring systems market can be majorly attributed to rising geriatric population. According to Population Reference Bureau, in 2018 the number of Americans of age group 65 & older was around 52 million. This number is projected to reach nearly 95 million by 2060. Geriatric population is associated with several age-related anatomic, physiologic and metabolic changes hence there is an inherent risk of morbidity and mortality during surgeries among such patients. Hence, it is highly important to closely monitor the patient’s cardiovascular and hemodynamic condition to avoid any postoperative complications.

Hemodynamic Monitoring Systems Market Prominent Players

Some of the prominent players operating in the global hemodynamic monitoring systems market are Edwards Life sciences Corporation, Konin klijke Philips N.V., Deltex Medical Limited, LiDCO, ICU Medical, Inc., CNSystems Medizin technik GmbH., PULSION MEDICAL SYSTEMS SE, NI Medical, CHEETAH MEDICAL Uscom, among others.

Surgical Robots Market Comprehensive Analysis, Development Strategy, Future Plans and Industry Growth by 2030

Surgical Robots Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030. The global surgical robots market is estimated to be over USD 4.31 billion in 2019. It is anticipated to grow witness precipitous growth of over 10.0% from 2019 to 2030.

The continual growth of the surgical robots market can be attributed to several factors which have led to wide scale adoption of minimally-invasive surgical procedures coupled with benefits associated with robotic surgeries. Moreover, the growing demand for robotic surgeries across the globe is anticipated to further contribute to the substantial growth of the global surgical robots market between 2019 and 2030.

Surgical Robots Market Prominent Players:

The prominent players in the global surgical robots market are Intuitive Surgical, Mazor Robotics, Zimmer Biomet (Medtech), Auris Health, Inc. (Hansen Medical), TransEnterix Surgical, Inc., Stryker, Smith & Nephew, Renishaw plc, Medrobotics and THINK Surgical, Inc.

Stem Cell Assay Market 2020 – Impact of COVID-19, Future Growth Analysis to Grow at a CAGR of 19.9% From 2030

The global stem cell assay market was valued at over US$ 450.0 Mn. in 2017 and is anticipated to grow at a CAGR of 19.9% from 2019 to 2030. The major factors driving the growth of the market includes increasing burden of chronic diseases, growing investment in R&D, and technological developments in biotech and pharmaceutical industry.

Major Players in the market focusing on R&D

Key players operating in the global stem cell assay market are Thermo Fisher Scientific, Promega Corporation, STEMCELL Technologies Inc., Merck KGaA, GE Healthcare, Bio-Techne Corporation, Hemogenix, Bio-Rad Laboratories, Inc., Cellular Dynamics International Inc., and Cell Biolabs Inc.

Nebulizers Market Analysis, Current and Future Trends, 2020 – 2030

The Global Nebulizers Market accounted for over US$ 890 million in 2019. It is anticipated to grow at a CAGR of 6.3% from 2019 to 2030.

The market growth of nebulizers can be attributed to factors, such as growing geriatric population, increase in prevalence of respiratory diseases, and smoking (a prime cause for COPD and asthma), increasing air pollution and the presence of toxins and allergens in air. According to Global Initiative for Chronic Obstructive Lung Disease, around 10 million people develop tuberculosis and 1.6 million die from it each year, making it the most lethal infectious disease. These are some of the prime factors boosting market growth.

Top Players:

Some of the prominent players in the global nebulizers market include Briggs Healthcare, Besco Medical, DeVilbiss Healthcare LLC, Feellife Health Inc., Convexity Scientific Inc., Invacare Corporation., Koninklijke Philips N.V., PARI, Omron Healthcare, Inc., Aerogen, and others.

Sleep Apnea Devices Market to See Huge Growth by 2030 | Players ResMed, Koninklijke Philips N.V.

The global sleep apnea devices market is estimated to be over US$ 4 Billion in 2017. It is anticipated to grow at a CAGR of 10.0% from 2019 to 2030.

The continual growth of the sleep apnea devices market can be attributed to several factors which have led to wide scale adoption of these products. Factors such as growing aging population and increase in lifestyle diseases like obesity, are further expected to contribute to the stable growth of the global sleep apnea devices market from 2019 to 2030. According to the National Healthy Sleep Awareness Project in 2015, it was revealed that obstructive sleep apnea affects more than 25 million people in the U.S. and it is a chronic disease that badly affects people. To obtain better insights regarding the market scenario, prominent players are increasingly focusing on collaborative initiatives with several institutes and research centers. For instance in 2018, Verily, a health data analytics company entered into an agreement with ResMed, a medical device manufacturer of sleep apnea. Both the companies have entered into a collaborative effort to study health and financial impacts of undiagnosed and untreated sleep apnea.

Top Players:

The prominent players in the global sleep apnea devices market are ResMed , Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, Compumedics Limited, DeVilbiss Healthcare LLC, BMC Medical Co., Ltd, VYAIRE, Curative Medical, Invacare Corporation and Somnetics International, Inc